neomycin sulfate 0.0035 MG/MG
- RxCUI
- 1093247
- RxNorm name
- neomycin sulfate 0.0035 MG/MG
- Term type
- SCDC
- Status
- Active
- Updated
- 2026-06-17 07:04:07
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042011
- Active start
- 042011
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| 0.0035 MG / 1 MG | neomycin |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| neomycin | 7299 |
Source Vocabulary Codes#
| Code type | Value | Category |
|---|---|---|
| PRESCRIBABLE | Y | ATTRIBUTES |
| RXNAV_STR | neomycin sulfate 0.0035 MG/MG | NAMES |
| RxNorm Name | neomycin sulfate 0.0035 MG/MG | NAMES |
| TTY | SCDC | ATTRIBUTES |
| RxCUI | 1093247 | CODES |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | A07AA | Antibiotics | ATC1-4 | neomycin | |
| ATC | S01AA | Antibiotics | ATC1-4 | neomycin | |
| ATC | R02AB | Antibiotics | ATC1-4 | neomycin | |
| ATC | B05CA | Antiinfectives | ATC1-4 | neomycin | |
| ATC | S03AA | Antiinfectives | ATC1-4 | neomycin | |
| ATC | S02AA | Antiinfectives | ATC1-4 | neomycin | |
| ATC | A01AB | Antiinfectives and antiseptics for local oral treatment | ATC1-4 | neomycin | |
| ATC | J01GB | Other aminoglycosides | ATC1-4 | neomycin | |
| ATC | D06AX | Other antibiotics for topical use | ATC1-4 | neomycin | |
| FDASPL | D000617 | Aminoglycosides | CHEM | has_chemical_structure | neomycin |
| FDASPL | N0000175477 | Aminoglycoside Antibacterial | EPC | has_epc | neomycin |
| MEDRT | D009355 | Neomycin | CHEM | has_ingredient | neomycin |
| MEDRT | D009355 | Neomycin | CHEM | has_ingredient | neomycin sulfate |
| MEDRT | D001424 | Bacterial Infections | DISEASE | may_prevent | neomycin |
| MEDRT | D001424 | Bacterial Infections | DISEASE | may_prevent | neomycin sulfate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | neomycin |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | neomycin sulfate |
| MEDRT | D004927 | Escherichia coli Infections | DISEASE | may_treat | neomycin |
| MEDRT | D004927 | Escherichia coli Infections | DISEASE | may_treat | neomycin sulfate |
| MEDRT | D006501 | Hepatic Encephalopathy | DISEASE | may_treat | neomycin sulfate |
| MEDRT | D006501 | Hepatic Encephalopathy | DISEASE | may_treat | neomycin |
| MEDRT | D006967 | Hypersensitivity | DISEASE | ci_with | neomycin sulfate |
| MEDRT | D015212 | Inflammatory Bowel Diseases | DISEASE | ci_with | neomycin |
| MEDRT | D015212 | Inflammatory Bowel Diseases | DISEASE | ci_with | neomycin sulfate |
| MEDRT | D007415 | Intestinal Obstruction | DISEASE | ci_with | neomycin |
| MEDRT | D007415 | Intestinal Obstruction | DISEASE | ci_with | neomycin sulfate |
| MEDRT | D017192 | Skin Diseases, Bacterial | DISEASE | may_treat | neomycin |
| MEDRT | D017192 | Skin Diseases, Bacterial | DISEASE | may_treat | neomycin sulfate |
| MEDRT | N0000000150 | Protein Synthesis Inhibitors | MOA | has_moa | neomycin |
| MEDRT | N0000000150 | Protein Synthesis Inhibitors | MOA | has_moa | neomycin sulfate |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | neomycin |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | neomycin sulfate |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | HYBRID |
| ATTRIBUTES | IN_EXPRESSED_FLAG | P |
| ATTRIBUTES | PRESCRIBABLE | Y |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | STRENGTH | 0.0035 MG/MG |
| ATTRIBUTES | TTY | SCDC |
| CODES | RxCUI | 1093247 |
| NAMES | RXNAV_STR | neomycin sulfate 0.0035 MG/MG |
| NAMES | RxNorm Name | neomycin sulfate 0.0035 MG/MG |